Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
Radiology ; 296(3): 710-714, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32804600

ABSTRACT

HistoryAn 18-year-old man was diagnosed with precursor B-cell lymphoblastic leukemia and underwent transplantation of hematopoietic stem cells from his human leukocyte antigen-matched sister 1 year prior to admission. He was admitted to evaluate progressive shortness of breath and dry cough of 1-month duration. He did not report fever, night sweats, or hemoptysis. Physical examination revealed he was afebrile and had normal pulse oxygen saturation. The examination revealed crepitation on palpation of the anterior neck, expiratory wheezes, and crackles heard at auscultation of bases of both lungs. Extensive maculopapular rash on the skin was consistent with graft-versus-host disease (GVHD). Laboratory tests revealed elevated liver transaminase and bilirubin levels that were attributed to liver GVHD. Nonenhanced thin-section CT of the chest was performed.


Subject(s)
Graft vs Host Disease , Hematopoietic Stem Cell Transplantation/adverse effects , Pulmonary Emphysema , Subcutaneous Emphysema , Adolescent , Dyspnea , Humans , Male , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Pulmonary Emphysema/diagnostic imaging , Pulmonary Emphysema/etiology , Subcutaneous Emphysema/diagnostic imaging , Subcutaneous Emphysema/etiology , Tomography, X-Ray Computed
2.
World Neurosurg ; 109: 117-118, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28962960

ABSTRACT

Acute lymphoblastic lymphoma is a malignant hematologic disease in childhood but rarely initially involves epidural compartment in adults. A 20-year-old male presented with progressive osphyalgia with constipation. Contrasted magnetic resonance imaging showed multiple vertebrae of hypointense T1 signals and an intraspinal epidural lesion. Subtotal resection was achieved. Histopathology suggested malignant B-cell lymphoma with Ki-67 of 90% and positivity of leukocyte common antigen. A bone marrow biopsy was unequivocally diagnostic of B-cell acute lymphoblastic lymphoma followed by chemotherapy (methotrexate) and partial recovery was observed. The marrow biopsy was necessary if without hypercalcemia and abnormal peripheral blood examination.


Subject(s)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Spinal Neoplasms/surgery , Spine/surgery , Antimetabolites, Antineoplastic/therapeutic use , Combined Modality Therapy , Humans , Magnetic Resonance Imaging , Male , Methotrexate/therapeutic use , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Spinal Neoplasms/diagnostic imaging , Spinal Neoplasms/drug therapy , Spine/diagnostic imaging , Young Adult
4.
BMJ Case Rep ; 20162016 Nov 29.
Article in English | MEDLINE | ID: mdl-27899386

ABSTRACT

Thyroid abscess is a very rare clinical condition. It usually occurs in immunocompromised individuals or those with underlying malignancy. We report a case of multiple thyroid abscesses in the patient with Pre B acute lymphoblastic leukaemia which developed secondary to hematogenous spread from pyomyositis of right calf muscle. The patient developed sepsis-associated disseminated intravascular coagulation, which got resolved after thyroidectomy. He became afebrile after surgical intervention. Unfortunately, all the cultures were negative. Since there are few case series and reports, there are no clear guidelines for management of thyroid abscess. We conclude that though rare, thyroid abscess may be the cause of persistent fever in immunocompromised patients.


Subject(s)
Abscess/pathology , Anti-Bacterial Agents/therapeutic use , Drainage , Fever/therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Pyomyositis/diagnosis , Sepsis/diagnosis , Thyroid Diseases/pathology , Thyroid Gland/pathology , Thyroidectomy , Adolescent , Antineoplastic Combined Chemotherapy Protocols , Clindamycin/therapeutic use , Fever/etiology , Fever/pathology , Humans , Male , Meropenem , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Prednisolone/therapeutic use , Pyomyositis/complications , Pyomyositis/drug therapy , Sepsis/drug therapy , Sepsis/etiology , Teicoplanin/therapeutic use , Thienamycins/therapeutic use , Thyroid Diseases/etiology , Thyroid Diseases/surgery , Treatment Outcome
5.
Int J Hematol ; 99(6): 790-3, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24789124

ABSTRACT

We report the case of a 75-year-old man who presented for evaluation of painless hematuria persisting for more than 1 month. At the time of presentation, the patient did not report any systemic symptoms and had no fever, weight loss, or dysuria. Computed tomography showed several enhancing, sessile polyps in the gall bladder (1.5 cm or smaller). There was no associated stone or biliary dilation. Since no other abnormality was evident, we performed laparoscopic cholecystectomy. He was diagnosed as having B-cell lymphoblastic lymphoma (B-LBL) after surgical resection of the gall bladder (GB). As the left mandibular swelling was developed after the diagnosis of the B-LBL involving GB, facial magnetic resonance imaging (MRI) was added to the imaging scan. Facial MRI revealed mass formation in the left mandible, left medial pterygoid, masticator, and buccinator muscles. The biopsy samples from the mandibular bone were also diagnosed as B-LBL. The definitive pathological diagnosis was B-LBL, stage IV. Systemic chemotherapy was done with subsequent response in size of the left mandible mass.


Subject(s)
Bone Neoplasms/diagnosis , Bone Neoplasms/secondary , Gallbladder Neoplasms/pathology , Mandible/pathology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow/pathology , Bone Neoplasms/drug therapy , Cholecystectomy, Laparoscopic , Gallbladder Neoplasms/diagnosis , Gallbladder Neoplasms/surgery , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Treatment Outcome , Watchful Waiting
6.
Exp Clin Transplant ; 12(2): 171-2, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24702151

ABSTRACT

Thromboembolism is a complication of hematopoietic stem cell transplant. However, a literature search showed no previous reports of cerebral infarction during the thrombocytopenic stage after hematopoietic stem cell transplant. A 35-year-old woman with acute lymphoblastic leukemia (precursor B-cell type) was treated with hematopoietic stem cell transplant after induction and consolidation chemotherapy. On day 2 after transplant, she was unconscious, and had urinary incontinence and left hemiplegia. A computed tomography scan of the brain showed an acute ischemic infarct in the right middle cerebral artery region and an old infarct at the left thalamus without atherosclerosis. Factor VIII level was elevated (190%; normal range, 60% to 150%). She was treated with rehabilitation and low-dose aspirin. At 6 months after transplant, the leukemia remained in remission and she had no further thromboembolic events. This case suggests that prudent treatment of patients who have hematopoietic stem cell transplant may include monitoring for thromboembolism and testing factor VIII level before transplant.


Subject(s)
Factor VIII/metabolism , Hematopoietic Stem Cell Transplantation/adverse effects , Infarction, Middle Cerebral Artery/etiology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Thrombocytopenia/etiology , Thromboembolism/etiology , Acute Disease , Adult , Biomarkers/blood , Female , Humans , Infarction, Middle Cerebral Artery/blood , Infarction, Middle Cerebral Artery/diagnosis , Infarction, Middle Cerebral Artery/therapy , Risk Factors , Thrombocytopenia/blood , Thrombocytopenia/diagnosis , Thromboembolism/blood , Thromboembolism/diagnosis , Thromboembolism/therapy , Time Factors , Up-Regulation
7.
Pediatr Infect Dis J ; 32(10): 1149-50, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24067555

ABSTRACT

Rhino-orbito-cerebral mucormycosis is a rare fulminant opportunistic fungal infection that particularly occurs in immunocompromised patients. We present a case of fatal invasive rhino-orbito-cerebral mucormycosis complicated by bilateral thrombotic occlusion of the internal carotid artery with consequent cerebral infarction in a 5-year-old boy after hematopoietic stem cell transplantation for acute pre-B-cell lymphoblastic leukemia.


Subject(s)
Brain Diseases/pathology , Carotid Artery Thrombosis/pathology , Hematopoietic Stem Cell Transplantation/adverse effects , Mucormycosis/pathology , Opportunistic Infections/pathology , Brain Diseases/microbiology , Child, Preschool , Fatal Outcome , Humans , Male , Nose Diseases/microbiology , Nose Diseases/pathology , Opportunistic Infections/microbiology , Orbital Diseases/microbiology , Orbital Diseases/pathology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery
8.
Hematol Oncol ; 31(4): 206-12, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23616245

ABSTRACT

Despite improvements in treatment, the prognosis of relapsed or primary refractory acute lymphocytic leukemia (ALL) remains poor, and outcomes are worse in older adults with the short first complete remission (CR). Attainment of the second CR by salvage therapy would improve the survival of these patients and may enable them to undergo curative treatment with allogeneic hematopoietic stem cell transplantation. The fact that there are diverse salvage protocols for these adult patients but without a striking CR-induction efficacy indicates that efforts are still needed to indentify new effective reinduction regimens. In this study, the CAG regimen (cytarabine, 10 mg/m(2) subcutaneously every 12 h on days 1-14; aclarubicin, 5-7 mg/m(2) intravenously daily on days 1-8; and concurrent granulocyte colony-stimulating factor, 200 µg/m(2) /day subcutaneously) was administered to 25 patients with relapsed or refractory ALL, including 11 T-cell ALL (T-ALL) and 14 B-cell (B-ALL) patients (age range, 11-61 years; median age, 26 years), to assess its efficacy as a salvage therapy. One course of the CAG regimen resulted in an overall response [CR or partial remission (PR)] rate of 64%, a CR rate of 56% and generally mild adverse effects. An overall response was observed in all 11 T-ALL patients (10 CR and 1 PR) and 35.7% of B-ALL patients (p = 0.0009). The significant treatment potential of CAG regimen for relapsed or primary refractory ALL, especially for T-ALL patients, described in this report would prepare them for a second CR to pursue longer survival.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Salvage Therapy , Aclarubicin/administration & dosage , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Child , China , Combined Modality Therapy , Cytarabine/administration & dosage , Disease-Free Survival , Drug Evaluation , Drug Resistance, Neoplasm , Female , Granulocyte Colony-Stimulating Factor/administration & dosage , Hematopoietic Stem Cell Transplantation , Humans , Male , Middle Aged , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery , Recurrence , Retrospective Studies , Treatment Outcome , Young Adult
10.
J Pediatr Hematol Oncol ; 34(6): e246-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22584779

ABSTRACT

Necrotizing fasciitis is a potentially life-threatening infection of deep skin layers and subcutaneous tissues that can easily spread across the fascia plate and is usually the result of a combined infection with anaerobic and aerobic microorganisms. The patient typically complains of excruciating pain, which is not necessarily in accordance with clinical signs. Early recognition of the condition is very important, and aggressive treatment with a combination of antibiotics and surgical procedure is crucial. We present a case of a 15-year-old girl with acute lymphoblastic leukemia who developed necrotizing fasciitis after venous access port implantation during induction chemotherapy.


Subject(s)
Catheterization, Central Venous/adverse effects , Catheters, Indwelling/adverse effects , Fasciitis, Necrotizing/etiology , Postoperative Complications , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/complications , Serratia Infections/etiology , Serratia marcescens , Adolescent , Female , Humans , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Prognosis
12.
Singapore Med J ; 52(12): e258-61, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22159948

ABSTRACT

A 20-year-old woman presented with multiple painless nodular swellings on the skin of the extremities and face, without any systemic symptoms. Biopsy with immunohistochemistry revealed a diagnosis of precursor B-cell lymphoblastic lymphoma. There was no extracutaneous site of involvement. The patient denied chemotherapy and was subsequently lost to follow-up. She presented with symptomatic disseminated disease 18 months later and rapidly succumbed to her illness.


Subject(s)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery , Adult , Biopsy/methods , Chromatin/metabolism , Fatal Outcome , Female , Humans , Immunohistochemistry/methods , Mitosis , Skin/pathology , Skin Neoplasms/pathology
13.
Article in Spanish | MEDLINE | ID: mdl-22011663

ABSTRACT

26 year-old male patient with diagnosis of acute lymphoblastic leukemia in 2006, who underwent chemotherapy and suffered a relapse and pulmonary aspergillosis as a complication. In 2009, he received bone marrow transplant. After it, he developed cutaneous and intestinal graft versus host disease (GVH). He was admitted for diarrhea. Then he presented grade IV dyspnea, patchy alveolar infiltrates on chest computed tomography and pancytopenia with impaired renal function as laboratory findings. He entered Intensive Care Unit, dying 7 days later. The oncologist who discussed the case defined this patient as a high risk case because of type of transplant received, relapse and complications. His diagnostic hypotheses were: CMV infection, pulmonary aspergillosis reactivation, chronic GVH, Pneumocystis jiroveci infection, mycobacteriosis and pseudomembranous colitis. Partial autopsy revealed diffuse intra-alveolar hemorrhage, diffuse alveolar damage, right pulmonary infarction with microthrombosis and bronchiolitis obliterans organizing pneumonia.


Subject(s)
Bone Marrow Transplantation/adverse effects , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Adult , Autopsy , Fatal Outcome , Humans , Male , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology
14.
Transfus Apher Sci ; 45(2): 187-90, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21890415

ABSTRACT

Sclerodermatous chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplantation (HSCT) in children is difficult to treat and life-threatening. Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy that involves the infusion of autologous peripheral blood leukocytes after ex vivo exposure to the photoactive agent 8-methoxypsoralen and ultraviolet A radiation, is an effective treatment for steroid-refractory cGVHD. After undergoing allogeneic HSCT for pre-B-cell acute lymphoblastic leukemia, a 14-year-old boy developed extensive sclerodermatous cGVHD that was refractory to prednisone, tacrolimus, and sirolimus. ECP was administered over the course of 53 months, during which the skin softened substantially and immunosuppressive therapy was discontinued. This case suggests that long-term ECP is a viable option in children with sclerodermatous cGVHD.


Subject(s)
Graft vs Host Disease/drug therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Photopheresis/methods , Scleroderma, Systemic/drug therapy , Adolescent , Chronic Disease , Humans , Male , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Prednisone/therapeutic use , Transplantation, Homologous , Treatment Outcome
16.
Arch Gynecol Obstet ; 284(5): 1289-92, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21193918

ABSTRACT

INTRODUCTION: Primary lymphomas of the female genital tract are rare. Most involve the cervix rather than the uterine corpus. Many cases of primary endometrial lymphoma are diagnosed as diffuse large B cell type, whereas the precursor B cell lymphoblastic type is extremely rare. MATERIALS AND METHODS: We report a case of precursor B cell lymphoblastic lymphoma of uterine corpus which was successfully treated with surgery and chemotherapy. Staging evaluation revealed tumor limited to the uterine corpus (stage I(E)). After receiving a total abdominal hysterectomy, bilateral salpingooophorectomy, lymph node dissection and combination chemotherapy, the patient is currently free of disease after follow-up of 42 months. CONCLUSION: If correct diagnosis is established and appropriate therapy is chosen, the prognosis of precursor B-LBL of uterine corpus is expected to be good. The literature on primary precursor B cell lymphoblastic lymphoma of the uterine corpus is reviewed.


Subject(s)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/therapy , Uterine Neoplasms/therapy , Adult , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols , Combined Modality Therapy , Female , Humans , Hysterectomy/methods , Lymph Node Excision , Ovariectomy/methods , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Uterine Neoplasms/drug therapy , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery
19.
J Pediatr Adolesc Gynecol ; 22(4): e65-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19493520

ABSTRACT

BACKGROUND: Acute lymphoblastic leukemia is a malignant disease of the bone marrow in which early lymphoid precursors proliferate and replace normal marrow hematopoietic cells, resulting in a marked decrease in the production of normal blood cells. CASE REPORT: We report a case of isolated ovarian relapse 7 years after the primary diagnosis in a patient, who was seemingly in clinical remission following unilateral ovariectomy and second-line chemotherapy. CONCLUSION: In contrast to testicular relapse, ovarian relapses in acute lymphoblastic leukemia are rarely reported. Surgical removal of the mass followed by chemotherapy is the therapeutic standard.


Subject(s)
Ovarian Neoplasms/secondary , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Adolescent , Female , Humans , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Ovariectomy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery
20.
Article in English | MEDLINE | ID: mdl-19426901

ABSTRACT

This case report describes the clinical case of relapse of precursor B-cell acute lymphoblastic leukemia in the jaw of a 19-year-old female patient who presented with facial swelling, sensory disturbances of the face, and teeth mobility 10 months after a successful allogenic bone marrow transplant. The oral and dental presentations were the only features indicating leukemic relapse in this patient.


Subject(s)
Mandibular Neoplasms/pathology , Neoplasm Recurrence, Local/pathology , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Bone Marrow Transplantation , Female , Humans , Leukemic Infiltration , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...